Clinical trial
D2 Versus D3 Dissection in Laparoscopic Right Hemicolectomy In Right Cancer Colon Patients: A Randomized Controlled Trial
NCT06049758 is registered in ClinicalTrials.gov with General Committee of Teaching Hospitals and Institutes, Egypt as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- D2 Versus D3 Dissection in Laparoscopic Right Hemicolectomy In Right Cancer Colon Patients: A Randomized Controlled Trial
- Lead sponsor
- General Committee of Teaching Hospitals and Institutes, Egypt
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- January 2, 2024
- Completion date
- January 2, 2030
- Enrollment
- 80 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
anastomotic leakage, blood loss, blood transfusion, intensive care, lymph node disease, survival